ADVFN - Advanced Financial Network.
HOME» NYSE » W » WPI Stock Price » WPI Stock News

Watson Share News

 Watson Pharmaceuticals, Inc. Stock Price
WPI Stock Price
 Watson Pharmaceuticals, Inc. Stock Chart
WPI Stock Chart
 Watson Pharmaceuticals, Inc. Stock News
WPI Stock News
 Watson Pharmaceuticals, Inc. Company Information
WPI Company Information
 Watson Pharmaceuticals, Inc. Stock Trades
WPI Stock Trades

Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency Contraceptive

By Melodie Warner Watson Pharmaceuticals Inc.'s (WPI) generic version of Teva Pharmaceutical Industries Ltd.'s (TEVA, TEVA.TV) Plan B One-Step emergency contraceptive obtained U.S. Food and Drug Administration approval. Plan B One-Step, sometimes called the "day-after pill," is used to prevent pregnancy following unprotected intercourse or a known or suspected contraceptive failure. Watson said it plans to immediately launch its product as Next Choice One Dose. The company said market-researcher IMS Health puts U.S. sales of Plan B One-Step at $88 million for the year ending May 31. In April, Watson reported its first-quarter earnings rose 22% as it recorded sharply higher revenue with a boost from new generic drugs and as its branded pharmaceuticals and distribution business also posted double-digit growth. -Write to Melodie Warner at [email protected]

Stock News for Watson (WPI)
No Recent News Available

Watson Pharmaceuticals and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations